claim
Shum et al. (2020) proposed that CB1 receptor-mediated dampening of neurite growth involves ERK and Akt signaling pathways, and demonstrated that the neurite growth ratio could be restored to control levels by the CB1 antagonist SR141716 in human-induced pluripotent stem cell-derived neurons.

Authors

Sources

Referenced by nodes (1)